OQS
ABCL icon

Occudo Quantitative Strategies’s AbCellera Biologics ABCL Stock Holding History

Occudo Quantitative Strategies’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,630
Closed -$61.7K – 719
2024
Q1 		$61.7K Buy
+13,630
New +$69.6K 0.01% 681
2022
Q4 		– Sell
-162,885
Closed -$1.61M – 919
2022
Q3 		$1.61M Buy
162,885
+68,562
+73% +$752K 0.13% 242
2022
Q2 		$1M Sell
94,323
-22,445
-19% -$190K 0.08% 383
2022
Q1 		$1.14M Buy
116,768
+89,901
+335% +$851K 0.1% 342
2021
Q4 		$384K Buy
+26,867
New +$408K 0.03% 696

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return